Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 15,000 shares at $127.84 ($1.9M) on 2015-04-20, disclosed to the SEC on 2015-04-22.
Scheduled sale ($1.9M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.53 | 2,520 | $311K | 16.5% |
| 2 | $124.71 | 1,689 | $211K | 11.1% |
| 3 | $125.62 | 5,457 | $686K | 36.3% |
| 4 | $126.68 | 750 | $95K | 5.0% |
| 5 | $127.84 | 3,875 | $495K | 26.2% |
| 6 | $128.25 | 11 |
| $1K |
| 0.1% |
| 7 | $130.57 | 628 | $82K | 4.3% |
| 8 | $131.29 | 70 | $9K | 0.5% |
| Total | $126.03 avg | 15,000 | $1.9M | 100% |
| Filing → |
| BLUE | SELL | 2015-05-19 | $2.3M | — | Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-08 | $1.8M | — | Filing → |